Aquila Janus Laboratories Private Limited

Aquila Janus Laboratories Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24304AP2019PTC111700 Incorporated 15 April 2019 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2023
₹2.4 Cr
▼ 43% YoY
Net profit · FY 2023
₹5.38 Lakh
Net margin 2.2%
EBITDA · FY 2023
₹7.79 Lakh
EBITDA margin 3.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Aquila Janus Laboratories Private Limited

Data last updated:

Aquila Janus Laboratories Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 April 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24304AP2019PTC111700. Its GSTIN is 37AASCA1778Q1ZN (Andhra Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Stanley Prasan Sundara and Sandhya Sundara.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7 – 5 – 141 Eastern Avenue Apartments Panduranga Puram, Visakhapatnam, Andhra Pradesh, India – 530003.

As per the financials filed for FY 2023, the company reported a revenue of ₹2.4 Cr, a decline of 43% compared to the previous year. For the same year it recorded a net profit of ₹5.38 Lakh (net margin 2.2%) and EBITDA of ₹7.79 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 109% over three years.

Aquila Janus Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0041439).

Company details

CIN U24304AP2019PTC111700
Registration Number 111700
Incorporation Date 15 April 2019
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-AP-10-0041439

Recognitions & Rankings of Aquila Janus Laboratories

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-AP-10-0041439

Contact details

Aquila Janus Laboratories Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    7 – 5 – 141 Eastern Avenue Apartments Panduranga Puram, Visakhapatnam, Andhra Pradesh, India – 530003
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Aquila Janus Laboratories Private Limited, buy the company report.

Comprehensive company report
Aquila Janus Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Aquila Janus Laboratories Private Limited

FY 2025 filings available

Aquila Janus Laboratories Private Limited reported revenue of ₹2.4 Cr (down 43% YoY) for FY 2023.

Revenue · FY 2023
₹2.4 Cr ▼ 43%
Net profit · FY 2023
₹5.38 Lakh margin 2.2%
EBITDA · FY 2023
₹7.79 Lakh margin 3.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 43%
3 years · compounded
▲ 109%

Revenue fell 43% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 109%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹2.4 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.79 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.38 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.2%
Net Profit Margin2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aquila Janus Laboratories Private Limited, buy the company report.

Board of directors of Aquila Janus Laboratories Private Limited

Aquila Janus Laboratories has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Stanley Prasan SundaraDirector15 Apr 20197 Years 6 MonthsCurrent
Sandhya SundaraDirector15 Apr 20197 Years 6 MonthsCurrent
Bhanu Zippora MuppidiDirector15 Apr 20197 Years 6 MonthsCurrent
Mohan Prasad ReddiDirector24 Jan 20206 Years 9 MonthsCurrent

Auditor

Aquila Janus Laboratories Private Limited is audited by RAMAMOORTHY (N) & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RAMAMOORTHY (N) & COFY 2023002899S

Shareholding

The shareholding of Aquila Janus Laboratories Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aquila Janus Laboratories Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aquila Janus Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Aquila Janus Laboratories has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AASCA1778Q1ZNAndhra PradeshActive27 Jun 2019

To see the full GST registrations and return filing status of Aquila Janus Laboratories Private Limited, buy the company report.

Recent activity

Aquila Janus Laboratories Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Mohan Prasad Reddi was appointed as Director on 24 Jan 2020.

AGM
Aquila Janus Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aquila Janus Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Appointed
Mohan Prasad Reddi was appointed as Director.
Appointed
Bhanu Zippora Muppidi was appointed as Director.
Appointed
Sandhya Sundara was appointed as Director.
Appointed
Stanley Prasan Sundara was appointed as Director.
Incorporation
15 Apr 2019
Aquila Janus Laboratories Private Limited was registered on 15 Apr 2019 with Roc Vijayawada & aged 7 years 6 months as per MCA records.

Frequently asked questions

Aquila Janus Laboratories is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 April 2019 (7+ years old) and is registered under CIN U24304AP2019PTC111700.

Aquila Janus Laboratories has 4 current directors:

The latest financial statements of Aquila Janus Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Aquila Janus Laboratories is 37AASCA1778Q1ZN, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Aquila Janus Laboratories is U24304AP2019PTC111700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aquila Janus Laboratories was incorporated on 15 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.

Mohan Prasad Reddi was appointed as Director on 24 Jan 2020. Bhanu Zippora Muppidi was appointed as Director on 15 Apr 2019. Sandhya Sundara was appointed as Director on 15 Apr 2019. Aquila Janus Laboratories has 4 board changes on record in total.

Yes, Aquila Janus Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-10-0041439).

The registered office of Aquila Janus Laboratories is at 7 – 5 – 141 Eastern Avenue Apartments Panduranga Puram, Visakhapatnam, Andhra Pradesh, India – 530003.

Aquila Janus Laboratories operates in the pharma industry, in the drug formulation and development segment.